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Edited by Giulio Superti-FurgaAbstract Nuclear factor jB (NF-jB) is associated with the
transcriptional activation of genes encoding chemokines, adhe-
sion molecules, cytokines, and anti-apoptotic proteins, which
are key components in immune responses and viral infection.
Many viruses modulate NF-jB through numerous viral gene
products to allow productive infections and immune escape. Here
we report that herpes simplex virus-1 infected cell protein 27
(HSV-1 ICP27), an immediate early protein of HSV-1, re-
presses NF-jB activity through binding to inhibitor of jB
(IjBa), blocking phosphorylation and ubiquitination of IjBa,
and stabilizing IjBa. These data may explain how NF-jB activ-
ity is regulated by ICP27 to escape immune responses during the
very early period of HSV-1 infection.
Structured summary:
MINT-6549405:
IkappaBalpha (uniprotkb:P25963) physically interacts
(MI:0218) with ICP27 (uniprotkb:Q9J0X9) by anti bait coim-
munoprecipitation (MI:0006)
MINT-6549385:
IkappaBalpha (uniprotkb:P25963) physically interacts
(MI:0218) with ICP27 (uniprotkb:Q9J0X9) by anti tag coim-
munoprecipitation (MI:0007)
MINT-6549372:
IkappaBalpha (uniprotkb:P25963) physically interacts
(MI:0218) with ICP27 (uniprotkb:Q9J0X9) by pull down
(MI:0096)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Many viruses exploit their hosts by expressing numerous viral
proteins that modulate the hosts signaling pathways including
cell growth, cell death, and immune response [1]. Among these
pathways, nuclear factor jB (NF-jB) coordinates the expres-
sion of genes involved in immune response, inﬂammation,
development, and apoptosis [2,3]. The regulation of NF-jB is
an important feature of many viral infections [4]. In most cells,
inactive NF-jB dimer is sequestered in the cytoplasm by IjBs,Abbreviations: NF-jB, nuclear factor jB; HSV-1 ICP27, herpes
simplex virus-1 infected cell proteins 27; EMSA, electrophoretic
mobility shift assay; IKK, IjB kinase; CHX, cycloheximide
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pathogens, inactive NF-jB dimer is activated through phos-
phorylation of IjBa by IjB kinase (IKK) complex containing
IKKa, IKKb, and IKKc. The phosphorylation of IjBa triggers
its ubiquitination followed by 26S proteasome-mediated degra-
dation. NF-jB released from IjBa translocates to the nucleus,
binds to jBbindingmotif in promoters of target genes, and acti-
vates the transcriptions of target genes [2,5–7].
Herpes simplex virus 1 (HSV-1) has evolved several regulatory
mechanisms to escape from host immune responses [8,9]. The
escape ofHSV-1 from immune surveillance is crucial for viral la-
tency and reactivation, which are speciﬁc biological phenomena
of HSV-1 infection. To evade immune surveillance, NF-jB
activity should be regulated, but NF-jB activation is observed
in HSV-1-infected cells [10,11]. However, it has been reported
that HSV-1 infection reduces NF-jB trans-activation function,
even though NF-jB is translocated to the nucleus [12]. Still, it is
unclear which viral components of HSV-1 modulate NF-jB
activity and how these viral proteins regulate it. Recently, it
was reported that NF-jB activity is inhibited during immedi-
ate early gene expression in cells infected with HSV-1 [13].
Among the immediate early proteins of HSV-1, ICP27 is an
essential protein for productive infection and is associated with
viral latency and reactivation. ICP27 is a multifunctional pro-
tein that is required in viral DNA replication and is responsible
for regulating viral gene expression as a switch from early to
late gene expression [14].
However, activation of NF-jB was strongly augmented in
macrophages infected with HSV-1 lacking functional ICP27,
suggesting that ICP27 represses NF-jB [12]. However, activa-
tion of NF-jB was strongly augmented in macrophages in-
fected with HSV-1 lacking functional ICP27, suggesting that
ICP27 represses NF-jB Thus, the molecular mechanism of
NF-jB modulation by ICP27 remains to be elucidated.
There has been no report on the direct eﬀect of ICP27 on the
regulation of NF-jB. Therefore, it is necessary to test the di-
rect role of HSV-1 ICP27 in the regulation of NF-jB associ-
ated with evasion of immune surveillance, latency, and
reactivation. Here, we report that ICP27 represses NF-jB
activity. Furthermore, we found that the inhibition of NF-
jB activity by ICP27 was caused by blocking the phosphoryla-
tion and ubiquitination of IjBa, followed by stabilization of
IjBa through interaction between ICP27 and IjBa.2. Materials and methods
2.1. Cells and HSV-1 infection
293T cells, Vero cells, and 3–3 cells were maintained in DMEM
supplemented with 10% fetal bovine serum at 37 C in 5% CO2. 3–3
cells (Vero cells expressing HSV-1 ICP27) were kind gifts from Dr.blished by Elsevier B.V. All rights reserved.
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ICP27 deletion mutant virus were propagated and titered on Vero cells
and 3–3 cells, respectively. For virus infection, cell monolayers were in-
fected at a multiplicity of infection (MOI) of 10 plaque forming units
(PFU)/cell.
2.2. Plasmids and proteins
IKKa, IKKb, and NIK expression plasmids were provided by Dr.
Warner C. Greene [15,16]. The dominant negative mutant of IjBa
(IjBa-SR) expression plasmid was provided by Dr. H. Nakshatri
[12]. ICP0 and ICP4 expression plasmid was provided by Dr. S. Rice
[17]. ICP22 expression plasmid was provided by Dr. J. Hauber [18].
PIASxb expression plasmid was provided by Dr. T. Ohshima [19].
p65 expression plasmid was provided by Dr. C. Joe [20]. The ICP27
gene was ampliﬁed from pSG424-ICP27 plasmid by PCR and cloned
into pGEX 4T-1 vector for expression of glutathione S transferase
(GST) fused ICP27 protein in Escherichia coli. The ICP27 gene was
subcloned into vectors pFlag-CMV-2 and pEBG to express Flag-
ICP27 and GST-ICP27, respectively, in mammalian cells.
2.3. Luciferase reporter assay and electrophoretic mobility shift assay
(EMSA)
For luciferase reporter assays, 293T cells (1 · 105 cells/plate) were
transfected with NF-jB luciferase reporter, pSV2-b-galactosidase,
and plasmids expressing various HSV-1 immediate early proteins. At
48 h after transfection, luciferase and b-galactosidase assays were per-
formed. For EMSA, nuclear extracts were prepared from 293T cells as
previously described [20]. Nuclear extracts were suspended in binding
buﬀer. Binding reactions were initiated by addition of 32P-labeled
DNA probe and incubated at room temperature for 30 min. The se-
quence of oligonucleotides used for NF-jB DNA binding was 5 0-
AGTTGAGGGGACTTTCCCAGGC-3 0. Reaction mixtures were
electrophoresed on non-denaturing 5% polyacrylamide gel. Gels were
dried and visualized by autoradiography.
2.4. GST pull down and immunoprecipitations
293T cells (1 · 106) were transiently cotransfected with GST-IjBa
and Flag-ICP27. At 36 h after transfection, cells were lysed in IPH buf-
fer (50 mM Tris–Cl pH 8.0, 150 mM NaCl, 0.5% Nonidet-P40, 5 mM
EDTA) with protease inhibitor cocktail (Roche) at 4 C for 30 min.
Cell lysates were prepared by centrifugation at 14000 rpm for 10 min
at 4 C Glutathione Sepharose 4B beads were added to lysates and
incubated at 4 C for 2 h. The beads were collected by centrifugation,
suspended in sample buﬀer, and boiled for 5 min. The bead complexes
were resolved by SDS–PAGE, blotted to PVDF membranes, and sub-
jected to Western blot analysis.
For immunoprecipitation assays, 293T cells were transiently
cotransfected with Flag-ICP27 and HA-IjBa. At 36 h after transfec-
tion, cell lysates were prepared and incubated with anti-Flag antibody
at 4 C for 2 h. Protein A sepharose beads were then added and the
mixtures were rotated at 4 C for 2 h. The immunoprecipitates were
collected by centrifugation and analyzed by SDS–PAGE and Western
blot analysis.
2.5. In vitro kinase assay for IKK
293T cells were cotransfected with either HA-IKKa or Flag-IKKb
expression plasmids together with Flag-ICP27. At 36 h after transfec-
tion, cell extracts were prepared and incubated with anti-HA antibody
or anti-Flag antibody at 4 C for 1 h. Protein A sepharose beads were
added and incubated at 4 C for 1 h. The immunocomplex-beads were
collected by centrifugation and resuspended in kinase buﬀer (10 mM
HEPES pH 7.4, 1 mM MnCl2, 12.5 mM b-glycerophosphate, 2 mM
NaF, 50 lM sodium orthovanadate, 50 lM DTT, 10 lM ATP). Im-
mune complex mixtures were incubated at 30 C for 30 min with
5 lCi [c-32P] ATP and GST fusion proteins, GST-IjBa and GST-
ICP27, prepared from E. coli. The in vitro kinase reaction mixtures
were resolved by SDS–PAGE and visualized by autoradiography.
For non-radioactive IKK kinase assay, cell extracts were prepared
and incubated with anti-IKKa/b antibody at 4 C for 1 h. Protein A
sepharose beads were added and incubated at 4 C for 1 h. The immu-
nocomplex-beads were collected by centrifugation and resuspended in
kinase buﬀer. Resuspended immune complex mixtures were incubated
with GST fusion proteins including GST-control, GST-ICP27, GST-
IjBa, and GST-p65 puriﬁed from 293T cells transfected with plasmidspEBG-control, pEBG-ICP27, pEBG-IjBa and pEBG-p65, respec-
tively. Reaction mixtures were subjected to SDS–PAGE and Western
blotting with anti-phospho-IjBa antibody or anti-phospho-p65 anti-
body.
2.6. Ubiquitination assay
Cells were cotransfected with plasmids expressing GST-IjBa,
ICP27, ICP22, and ubiquitin-HA. At 24 h after transfection, cell ly-
sates were prepared. Glutathione Sepharose 4B beads were added to
cell lysates and incubated at 4 C for 2 h. The bead complexes were col-
lected by centrifugation and suspended in sample buﬀer. The bead
complexes were analyzed by SDS–PAGE and Western blot analysis.3. Results
We previously reported that ICP27 sensitized cells to pro-
apoptotic stimuli [21]. Since NF-jB plays important roles in
the regulation of apoptosis, we speculated that ICP27 might
inﬂuence the regulation of NF-jB. To conﬁrm the eﬀect of
HSV-1 ICP27 on NF-jB activity, we performed luciferase re-
porter assays in 293T cells transfected with expression plas-
mids for ICP27 and other HSV-1 immediate early proteins.
ICP27 inhibited NF-jB activity, while ICP0 and ICP4 in-
creased NF-jB activity (Fig. 1A). Increased expression of
ICP27 resulted in decreased NF-jB activity in 293T cells
(Fig. 1B). In EMSA, ICP27 dose-dependently inhibited NF-
jB DNA binding activity (Fig. 1C).
To further characterize the suppression of NF-jB by ICP27,
we tested the eﬀect of ICP27 in the presence of NF-jB regula-
tory factors. We found that ICP27 inhibited the elevation of
NF-jB activity by TNF-a. The inhibitory eﬀect of ICP27
was also observed in the presence of the upstream inducers
of NF-jB, NF-jB inducing kinase (NIK) and IKK (Fig.
1D), which suggested that NF-jB was regulated by ICP27 act-
ing downstream of NIK and IKK.
In the NF-jB signaling pathway, the degradation of IjBa is
a pivotal step in NF-jB activation. Thus, the inhibition of NF-
jB by ICP27 could be due to an increase in IjBa stability by
ICP27. Therefore, the relative levels of IjBa were measured
in response to cell stimulation. 293T cells transfected with
ICP27 expression plasmid were incubated with cycloheximide
(CHX) for 1 h (Fig. 2A). As expected, CHX treatment de-
creased the level of IjBa in cells by blocking protein biosynthe-
sis. However, in the presence of ICP27, CHX treatment did not
aﬀect the level of IjBa, suggesting that ICP27 enhanced the
stability of IjBa. In the absence of CHX, ICP27 did not aﬀect
the levels of IjBa, suggesting that ICP27 did not alter the gene
expression of IjBa. Since turnover of IjBa is controlled by
26S proteasome-mediated degradation and the instability of
IjBa is tightly correlated with its phosphorylation at Ser32
and Ser36, we tested whether ICP27 enhanced IjBa stability
by inhibiting IjBa phosphorylation. As seen in Fig. 2B,
TNF-a induced phosphorylation and degradation of IjBa as
early as 5 min after treatment. However, in the presence of
ICP27, TNF-a did not induce phosphorylation and degrada-
tion of IjBa. In addition, ICP27 inhibited phosphorylation
and degradation of IjBa in a dose-dependent manner (Fig.
2C) Since proteasome-mediated degradation of IjBa is related
to its ubiquitination, ICP27 may inﬂuence the ubiquitination
of IjBa. To test whether ICP27 aﬀects the ubiquitination of
IjBa, we performed ubiquitination assays in 293T cells
cotransfected with plasmids expressing ICP27, GST-IjBa,
and ubiquitin-HA. Certainly ICP27 inhibited ubiquitination
Fig. 1. ICP27 inhibits NF-jB activity (A) 293T cells (1 · 105) were transfected with ICP0, ICP0 and ICP4, and ICP27 expression plasmids (0.2 lg) in
combination with NF-jB luciferase reporter construct (0.2 lg). The levels of NF-jB-induced luciferase activities were obtained from three
independent experiments. (B) 293T cells were transfected with increasing amounts of ICP27 expression plasmid (0, 0.1, 0.2, 0.3, 0.4, and 0.5 lg) and
NF-jB luciferase reporter construct. (C) 293T cells were transfected with increasing amounts of ICP27 expression plasmid (0, 0.2, and 0.4 lg) and
nuclear extracts were prepared for NF-jB EMSA. At 24 h after transfection, cells were stimulated with TNF-a (20 ng/ml) for 8 h. For competitive
reaction, nuclear extracts were preincubated with excess amount of unlabeled NF-jB oligonucleotide DNA probe. (D) 293T cells were transiently
cotransfected with combination of plasmids expressing ICP27, IjBa-SR, NIK, IKKa, and IKKb along with NF-jB luciferase reporter construct. At
24 h after transfection, cells were treated with TNF-a.
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not inhibited ubiquitination of IjBa (Fig. 2D). These results
suggested that ICP27 stabilizes IjBa by blocking phosphoryla-
tion and ubiquitination of IjBa.
Some stimuli for NF-jB activation aﬀect various kinases
that converge on the IKK complexes [22]. Since ICP27 inhib-
ited phosphorylation of IjBa and stabilized IjBa, ICP27
might also aﬀect IKK activity. To test the eﬀect of ICP27 on
IKK activity, HA-IKKa and Flag-IKKb were prepared by
immunoprecipitating the extracts of 293T cells cotransfected
with plasmids expressing HA-IKKa, Flag- IKKb, and
ICP27. In vitro kinase reactions were carried out using HA-
IKKa and Flag-IKKb, along with GST-ICP27 and GST-IjBa
puriﬁed from E. coli (Fig. 2E). It turned out that the coexpres-
sion of ICP27 in 293T cells did not reduce the kinase activities
of IKKa and IKKb (Fig. 2E, lane 3). Instead, puriﬁed GST-
ICP27 protein remarkably suppressed IjBa phosphorylation
by IKKa and IKKb kinases (Fig. 2E, lane 5). To conﬁrm that
ICP27 does not inhibit IKK activity and suppresses IjBa
phosphorylation by IKK, we tested whether ICP27 inhibited
IKK-mediated phosphorylation of p65, which is a substrateof IKK. Phosphorylation of GST-p65 by IKK was not inhib-
ited by ICP27, while phospoylation of GST-IjBa by IKK was
inhibited by ICP27 suggesting that ICP27 does not inhibit
IKK activities (Fig. 2F).
Some viral proteins inhibit NF-jB activity through binding
to IKK components [23,24]. Therefore, we tested whether
ICP27 has physical interaction with IKKs. However we found
that ICP27 did not bind to any of IKKs containing IKKa,
IKKb, IKKc and NIK (data not shown). Since puriﬁed
ICP27 protein repressed IKK-mediated IjBa phosphorylation
without reducing IKK activity, it is likely that ICP27 might in-
hibit IjBa phosphorylation through direct interaction with
IjBa. To ﬁnd the interaction between ICP27 and IjBa, we car-
ried out GST pull down assay using the extracts of cells trans-
fected with plasmids expressing GST-IjBa and Flag-ICP27.
Interestingly it turned out that ICP27 was pulled down by
GST-IjBa (Fig. 3A). We also performed coimmunoprecipita-
tion assay using the extracts of cells transfected with plasmids
expressing Flag-ICP27 and HA-IjBa. Certainly, ICP27 di-
rectly binds to IjBa (Fig. 3B). We further conﬁrmed that other
tagged proteins, Flag-PIASxb and HA-IKKa does not interact
Fig. 2. ICP27 enhances the stability of IjBa by inhibiting IjBa phosphorylation (A) 293T cells (1 · 106) were transfected with ICP27 expression
plasmid (6 lg). At 24 h after transfection, cells were treated with CHX for 2 h. Cell lysates were prepared and analyzed by 10% SDS–PAGE and
Western blotting to assess the level of IjBa. (B) 293T cells were transfected with ICP27 expression plasmid and stimulated with TNF-a for various
periods of time (0–60 min). TNF-a induced phosphorylation and degradation of IjBa were dissected by Western blot assay. (C) 293T cells were
transfected with various amounts of ICP27 expression plasmid (0, 3, and 6 lg). At 24 h after transfection, cells were incubated with TNF-a for 5 min.
Cell lysates were prepared and the levels of phosphorylation and degradation of IjBa were determined by Western blot analysis. (D) 293T cells were
cotransfected with plasmids expressing GST-IjBa, Flag-ICP27, GFP-ICP22, and ubiquitin-HA. At 24 h after transfection, cells were treated with
MG132 for 4 h and whole cell extracts were prepared. Cell extracts were pulled down with glutathione-Sepharose 4B, subsequently applied to SDS–
PAGE, and analyzed by Western blotting. (E) 293T cells were transfected with either HA-IKKa or Flag-IKKb expression plasmids in combination
with ICP27 expression plasmid. At 24 h after transfection, cells were treated with TNF-a for 5 min. Cell extracts were prepared and incubated with
antibodies against HA or Flag to immunoprecipitate HA-IKKa or Flag-IKKb respectively. For in vitro kinase reaction, immunocomplexes
containing IKKs were incubated with GST-IjBa and GST-ICP27 puriﬁed from E. coli. After in vitro kinase reaction, reaction mixtures were resolved
by SDS–PAGE and kinase activities (KA) were analyzed by autoradiography. (F) 293T cell extracts were incubated with anti-IKKa/b and protein A
sepharose beads were added. The immunocomplex-beads were collected by centrifugation and resuspended in kinase buﬀer. Resuspended immune
complex mixtures were incubated with either GST-ICP27 and GST-IjBa or GST-p65 and GST-IjBa for 30 min. The kinase reaction was stopped by
boiling with 2 · SDS sample buﬀer for 5 min. Reaction mixtures were subjected to SDS–PAGE and Western blotting with anti-phospho-IjBa
antibody or anti-phospho-p65 antibody.
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the association between ICP27 and IjBa is speciﬁc (Fig. 3C).
Since we investigated the protein interaction in cells transfec-
ted with plasmids expressing ICP27 and IjBa, we attempted
to conﬁrm whether the endogenous IjBa interacts with viral
ICP27 in HSV-1 infected cells. To test the interaction between
IjBa and viral ICP27, 293T cells were infected with HSV-1
and lysed at 2 h p.i. HSV-1 infected cell extracts were immuno-
precipitated with anti-IjBa antibody and the immunoprecipi-
tates were analyzed to SDS–PAGE and immunoblotting with
antibodies against ICP27 and IjBa. Precisely, viral ICP27
binds to endogenous IjBa in HSV-1 infected cells (Fig. 3D).
To conﬁrm whether the association between viral ICP27 and
endogenous IjBa is speciﬁc, we performed coimmunoprecipi-
tation with lysates prepared from cells infected with HSV-1
at very early phase of infection. It is evident that the direct
interaction between viral ICP27 and endogenous IjBa is de-
tected only when viral ICP27 is expressed after HSV-1 infec-
tion (Fig. 3E).
To conﬁrm the role of ICP27 upon regulation of NF-jB dur-
ing early period of HSV-1 infection, we compared the levels of
ICP27 and IjBa with NF-jB activities at early phase of HSV-1
infection (Fig. 4A). It turned out that NF-jB activity regulated
by wild-type HSV-1 infection has two controlled waves of NF-
jB activation correlating with the levels of IjBa and theexpression of ICP27 begins as early as 2 h p.i after HSV-1
infection. Interestingly, NF-jB activity is increased and the le-
vel of IjBa is decreased at 6 h p.i of HSV-1 infection while the
level of ICP27 is increased. These data suggest that other viral
proteins, early and late proteins including gD, might be in-
volved in the regulation of IjBa stability. Certainly NF-jB
activity is inhibited at immediate early phase and then NF-
jB activity is rescued and continues to increase over the time
course of infection. These results are consistent with previous
report [25]. However, ICP27 mutant virus did not exhibit the
suppression of NF-jB activity from 2 h p.i to 3 h p.i. (Fig. 4
B). These results suggested that ICP27 plays a role to repress
NF-jB activity at immediate early phase of infection through
correlation to IjBa.4. Discussion
Until now, it was unclear which HSV-1 viral components
modulated NF-jB activity. According to our data, ICP0 and
ICP4 appear to enhance NF-jB activity, while ICP27 clearly
represses NF-jB activity. Though there was a report that
ICP27 was required for nuclear translocation of NF-jB using
ICP27-mutant HSV-1, the molecular mechanism of NF-jB
activation by ICP27 was still unclear. Moreover, HSV-1 had
Fig. 3. ICP27 interacts with IjBa. (A) 293T cells were transfected with combination of Flag-ICP27 expression plasmid, Flag empty vector, GST-
IjBa expression plasmid, and GST empty vector. Whole cell extracts were prepared, pulled down with glutathione-Sepharose 4B, and analyzed by
Western blotting. (B) 293T cells were transfected with plasmids expressing Flag-ICP27 and HA-IjBa. At 36 h after transfection, whole cell extracts
were immunoprecipitated with anti-Flag antibody, followed by Western blot analysis. (C) 293T cells were transfected with combination of Flag-
ICP27 expression plasmid, Flag-PIASxb expression plasmid, Flag empty vector, HA-IjBa expression plasmid, HA-IKKa expression plasmid, and
HA empty vector. At 36 h after transfection, whole cell extracts were prepared and immunoprecipitated with anti-Flag antibody, followed by
Western blot analysis. (D) 293T cells were infected with HSV-1 at a MOI of 10 PFU/cell. At 2 h p.i., whole cell extracts were immunoprecipitated
with anti-IjBa antibody and analyzed by Western blotting. (E) 293T cells were either mock infected or infected with HSV-1 at a MOI of 10 PFU/cell.
At indicated time post-infection, whole cell extracts were prepared, immunoprecipitated with anti-IjBa antibody, and then immunoblotted with anti-
IjBa, anti-ICP27, and anti-b-actin antibodies.
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early gene expression [13] and HSV-1 lacking functional
ICP27 induced the expression of cytokines that are regulated
by NF-jB, suggesting that ICP27 inhibited NF-jB activity
[26]. We speculated the apparent discrepancies in these reports
were caused by the use of mutant virus that aﬀected not only
ICP27 expression, but also that of other genes. Furthermore,
the direct eﬀect of ICP27 on NF-jB activity might be masked
by that of other immediate early proteins, such as ICP0 and
ICP4, which enhance NF-jB activity. The regulation of NF-
jB activity by immediate early proteins may also be dependent
on post-infection time. It is also possible that the expression of
immediate early proteins might diﬀer depending on the host
cell type. We found that the expression of ICP27 began as early
as 2 h after HSV-1 infection (Fig. 3E). In addition, the levels of
IjBa were decreased even though the levels of ICP27 were in-
creased at 6 h p.i of HSV-1 infection suggesting that other viral
proteins, early and late proteins including gD, might be in-
volved in the regulation of IjBa stability (Fig. 4A). These ﬁnd-
ing may explain the diﬀerences between our data and other
reports [27].
As reported previously [13], HSV-1 activates NF-jB in a
biphasic way, though the overall eﬀect of HSV-1 on NF-jB
activation is very weak. We speculate that the weak eﬀect of
HSV-1 on NF-jB activation in 293T cells may be cell type spe-
ciﬁc, since HSV-1 infection in Vero cells exhibited more evi-dent NF-jB activation (data not shown). However, repressed
NF-jB activity from 2 h p.i to 3 h p.i of HSV-1 infection cor-
responds to the expression of ICP27 and the increased amount
of IjBa. When the ICP27 mutant virus was infected, even
though the suppression of NF-jB activity from 2 h p.i to 3 h
p.i was not dramatically recovered, reduced NF-jB repression
from 2 h p.i to 3 h p.i might suggest that ICP27 is involved in
the repression of NF-jB at early phase of viral infection.
In the present study, we found that HSV-1 ICP27 inhibited
NF-jB activity (Fig. 1). The inhibitory eﬀect of ICP27 on NF-
jB activity was exploited by luciferase assay and EMSA. We
also conﬁrmed that ICP27 inhibited NF-jB activity at the very
early phase of HSV-1 infection (Fig. 4). The inhibitory eﬀect of
ICP27 on phophorylation and ubiquitination of IjBa is
mainly caused by physical direct binding of ICP27 to IjBa
(Fig. 3). It is very clear that viral ICP27 interacts with cellular
IjBa, however the binding domain of ICP27 to IjBa remains
to be elucidated.
Taken together, we have elucidated for the ﬁrst time that
HSV-1 ICP27 suppresses NF-jB through the binding to IjBa.
We also found that the binding of ICP27 to IjBa stabilizes
IjBa through reducing the phosphorylation of IjBa by vari-
ous IKKs. This regulatory mechanism of ICP27 on NF-jB
activity may contribute to understand the escape of immune
surveillance related to NF-jB signal pathway at the very early
phase of HSV-1 infection.
Fig. 4. NF-jB activity is inhibited at early phase of HSV-1 infection. (A) 293T cells were infected with HSV-1 at a MOI of 10 PFU/cell for various
periods of time (0, 1, 2, 3, 6 h). Cell extracts were prepared and the levels of IjBa and viral ICP27 were determined by Western blot analysis. For NF-
jB activity analysis, 293T cells (1 · 106) were transfected with NF-jB luciferase reporter construct (0.2 lg). At 24 h after transfection, cells were
infected with HSV-1 at a MOI of 10 PFU/cell. At the indicated time post-infection, cell lysates were prepared and the luciferase activities were
determined. Relative NF-jB activities were obtained from three independent experiments. (B) 293T cells were infected with either HSV-1 or ICP27
deletion mutant virus at a MOI of 10 PFU/cell for various periods of time (0, 1, 2, 3, 6, 9 h). The levels of IjBa and viral ICP27 were determined by
Western blot analysis. For NF-jB activity analysis, 293T cells were transfected with NF-jB luciferase reporter plasmid. At 24 h after transfection,
cells were infected with either HSV-1 or ICP27 deletion mutant virus at a MOI of 10 PFU/cell. At indicated time post-infection, cell lysates were
prepared and the luciferase activities were determined. Relative NF-jB activities were obtained from three independent experiments.
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